Rights and permissions
About this article
Cite this article
FDA approves first-in-class bispecific for multiple myeloma. Nat Biotechnol 41, 1180 (2023). https://doi.org/10.1038/s41587-023-01962-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-023-01962-x
- Springer Nature America, Inc.